医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium

广告
第一作者: Maurer,B.J.
作者单位: Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States [1] Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, United States [2] Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco [3] Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia [4] Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles [5] New Approaches to Neuroblastoma Therapy (NANT) Consortium Operations Center, Childrens Hospital Los [6] Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock [7] Saban Research Institute, Keck School of Medicine, University of Southern California, Los Angeles [8] Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles [9] Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles [10] Department of Statistics, Keck School of Medicine, University of Southern California, Los Angeles [11]
发布时间 2014-01-22
提交
  • 浏览2
Pediatric blood & cancer

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷